Navigation Links
Abaxis Reports Record Revenues and Operating Income for the Second Quarter of Fiscal 2009
Date:10/27/2008

UNION CITY, Calif., Oct. 27 /PRNewswire-FirstCall/ -- Abaxis, Inc. (Nasdaq: ABAX), a medical products company manufacturing point-of-care blood analysis systems, today reported financial results for the fiscal quarter ended September 30, 2008.

Quarterly highlights include:

-- Record revenues of $27.7 million, up 10% over last year's comparable quarter.

-- Record operating income of $4.8 million, up 17% over last year's comparable quarter.

-- Record medical reagent disc sales of 434,000 units, up 28% over last year's comparable quarter.

-- Record veterinary market sales of $19.9 million, up 11% over last year's comparable quarter.

-- Record veterinary reagent disc sales over 1.0 million units, finishing at 1,003,000 units, up 11% over last year's comparable quarter.

-- Net income of $3.3 million, up 14% over last year's comparable quarter.

-- Cash, cash equivalents and short-term investments as of September 30, 2008 of $69.6 million, compared to $51.7 million as of September 30, 2007.

Quarterly Results: For the fiscal quarter ended September 30, 2008, Abaxis reported revenues of $27.7 million, as compared with revenues of $25.2 million for the comparable period last year, an increase of 10 percent. Instrument, reagent disc and hematology reagent revenues increased by an aggregate of $2.5 million, or 11 percent, for the quarter ended September 30, 2008 over the same period last year. The company reported net income of $3.3 million, compared to $2.9 million for the same period last year. The company's effective tax rate in the quarter ended September 30, 2008 was 36 percent, compared to 38 percent for the same period last year. The company reported diluted net income per share of
'/>"/>

SOURCE Abaxis, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Abaxis, Inc. to Present at the Sidoti & Companys Seventh Annual West Coast Emerging Growth Institutional Investor Forum
2. Abaxis Reports Financial Performance for the First Quarter of Fiscal 2009
3. Abaxis to Report Third Quarter Fiscal 2008 Financial Results Thursday, January 31, 2008
4. Abaxis CEO Clint Severson Named Entrepreneur of the Year by Forbes Magazine
5. Abaxis to Present at the Sidoti & Company Sixth Annual San Francisco Institutional Investor Forum Conference
6. Trubion Reports Re-treatment Results Following Phase 1/2a and Phase 2b Studies Evaluating TRU-015 for Rheumatoid Arthritis
7. BioCryst Reports Results From the First-Ever Completed Active-Controlled Phase 2 Study in Hospitalized Influenza
8. International Drug & Explosive Detection Firm Identa Corp Releasing: Jant Pharmacal Corporation Reports Successful Market Penetration of the Accutest(R) IDenta Co-brand in the United States and Oversees
9. Anadys Pharmaceuticals Reports Third Quarter 2008 Financial Results and Highlights
10. Aware, Inc. Reports Third Quarter 2008 Financial Results
11. Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the Second Quarter and First Six Months of Fiscal 2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/11/2009)... Corporation (Nasdaq: DNDN ) announced today that ... have exercised in full their option to purchase ... the public offering price of $24.75 per share. ... size of the offering to an aggregate of ... to receive net proceeds from the offering of ...
(Date:12/11/2009)... Dec. 11 Ambit Biosciences Corporation announced today ... M. D. Anderson Cancer Center of the first patient ... E fficacy) Phase 2 pivotal trial ... (AML). AC220 is a novel, orally available, potent ... as a FMS-like tyrosine kinase-3 (FLT3) inhibitor. The ...
(Date:12/11/2009)... - Oncolytics Biotech Inc. (TSX:ONC, NASDAQ: ONCY ) ... of Dr. Alan Warrander to the role of ... ,, "Dr. Warrander will be responsible for the ... said Dr. Brad Thompson, President and CEO of ... of a Phase 3 trial examining REOLYSIN in ...
(Date:12/10/2009)... Dec. 10 Endologix, Inc. (Nasdaq: ... aortic disorders, announced today that Dan Lemaitre, former ... Endologix Board of Directors effective December 11, 2009. ... three non-independent directors. ,, Franklin D. Brown, Chairman ... welcome Dan Lemaitre to the Endologix Board of ...
Breaking Biology Technology:Dendreon Announces Exercise of Option by Underwriters in its Common Stock Offering 2Dendreon Announces Exercise of Option by Underwriters in its Common Stock Offering 3Ambit Biosciences Initiates First Phase 2 Clinical Trial of AC220 in Acute Myeloid Leukemia 2Ambit Biosciences Initiates First Phase 2 Clinical Trial of AC220 in Acute Myeloid Leukemia 3Ambit Biosciences Initiates First Phase 2 Clinical Trial of AC220 in Acute Myeloid Leukemia 4Ambit Biosciences Initiates First Phase 2 Clinical Trial of AC220 in Acute Myeloid Leukemia 5Oncolytics Biotech(R) Inc. Appoints Senior Vice President, Global Licensing and Business Development 2Oncolytics Biotech(R) Inc. Appoints Senior Vice President, Global Licensing and Business Development 3Endologix Appoints Dan Lemaitre to its Board of Directors 2
... is available in German . , ... , is able to rapidly ,and efficiently detoxify chemical ... the Tokyo subway attacks in 1995. A detailed understanding ... is ,necessary for efforts aiming to improve their properties. ...
... Inc. (Nasdaq: ANDS ) announced today that ... Thursday, April 23, 2009, after the U.S. financial markets ... Thursday, April 23, 2009 at 5:00 p.m. Eastern Daylight ... and highlights and to provide an update on its ...
... clinical development solutions in North America, Europe and ... ClinPharm (SIRO), a leading multinational Contract Research ... strategic alliance with Advanced Clinical Trial Solutions LLC ... in oncology drug development with a business concentration ...
Other Biology Technology:Structure of enzyme against chemical warfare agents determined 2Anadys Pharmaceuticals to Report First Quarter 2009 Financial Results 2SIRO ClinPharm and Advanced Clinical Trial Solutions Ink Strategic Alliance 2
(Date:12/14/2009)... once thought of tool use as a defining feature of ... other primates, along with birds and an array of other ... Current Biology , a Cell Press publication, adds an ... veined octopus under study manages a behavioral trick that the ... itself over stacked, upright coconut shell "bowls," makes its eight ...
(Date:12/13/2009)... help to engineer plants that take advantage of elevated ... could help to engineer crops that take advantage of ... dioxide they need for photosynthesis through microscopic breathing pores ... of the gas gained, they lose hundreds of water ... to save water when CO 2 is abundant, ...
(Date:12/13/2009)... at The Scripps Research Institute have solved a ... an ancient family of enzymes can have two ... to providing guidance for understanding other molecules in ... for the protein,s possible use for combating diseases ... was published in the December 13, 2009 advance, ...
Breaking Biology News(10 mins):Tool use in an invertebrate: The coconut-carrying octopus 2Newly identified enzymes help plants sense elevated CO2 and could lead to water-wise crops 2Newly identified enzymes help plants sense elevated CO2 and could lead to water-wise crops 3Scripps Research scientists crack mystery of protein's dual function 2Scripps Research scientists crack mystery of protein's dual function 3Acetaminophen May Weaken Effectiveness of Kids Vaccines 59592 1Acetaminophen May Weaken Effectiveness of Kids Vaccines 59592 2Dr Julian Whitaker Pens Forward for Suzanne Somers 26apos 3B New Cancer Book 59588 1Dr Julian Whitaker Pens Forward for Suzanne Somers 26apos 3B New Cancer Book 59588 2LifeCare Hospitals Appoints New Executive Vice President of Operations 59584 1
... of seashells 15 years ago, Dr. Gary Rosenberg did ... light on a 40-year-old evolutionary debate. , The debate ... animals isolated on islands evolve to be larger than ... smaller. In a paper to be published in September ...
... virus called GB Virus type C (GBV-C) protects against HIV ... Veterans Affairs (VA) Iowa City Health Care System and the ... inhibits HIV from growing in cell models. , The team ... protein called NS5A greatly slows down HIV from replicating in ...
... look at the battlefield on which plant diseases are ... of Sheng Yang He at Michigan State University has ... and is unveiling new knowledge of how bacterial pathogens ... published in the Sept. 8 edition of Cell, redefines ...
Other Biology News:Scientist's persistence sheds light on marine science riddle 2Study IDs protein that inhibits HIV from growing in cell cultures 2Study IDs protein that inhibits HIV from growing in cell cultures 3Plants give up answers in the war on bacteria 2
... White solid. PROTECT FROM LIGHT. PACKAGED ... compound that acts as a selective, ... PTP1B (IC 50 = 4 ... 403 and PTP1B 298 , ...
...
BD Falcon microtest assay plate. 1536 well 12l, black BD Optilux PS. Polystyrene, nonsterile, no lid (15/sp, 60/ca) Packaging: 15 / pack, 60 / case ...
... washer 100-240 V, is used for washing ... V-bottom wells. The immunowash microplate washer has ... to an accuracy of 0.1 mm for ... It can store up to 75 wash ...
Biology Products: